Fundraising Fox

Ekso Bionics

Richmond, US · Founded 2012 · 108 employees on LinkedIn · 2 known investors

Ekso Bionics develops wearable exoskeleton robotics used to help people with paralysis stand and walk, to augment worker physical capabilities, and to support rehabilitation and R&D. It serves medical/rehabilitation and industrial markets in the healthcare robotics and medical device category.

Founders & leadership

JF
John F. Glennprincipal financial and accounting officer
JP
Jack Peurachprincipal executive officer
CL
Charles LiNamed on SEC filing
WS
William ShawNamed on SEC filing
SS
Stanley SternNamed on SEC filing
JJ
Jason JonesinNamed on SEC filing
TW
Ted WangNamed on SEC filing
TS
Thomas SchreckNamed on SEC filing
MH
Marilyn HamiltonNamed on SEC filing
SS
Steven ShermanNamed on SEC filing
SD
Scott DavisinChief Executive Officer
JW
Jerome WonginChief Financial Officer

Investors · 2

Reported raises · per SEC filings

Form D private placements

$103.3M disclosed across 4 of 6 rounds · 2014–2021

$3.5MofferedFeb 2021 · 4 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Jack PeurachExecutive Officer, Director
  • Steven ShermanExecutive Officer, Director
  • John F. GlennExecutive Officer
  • Marilyn HamiltonDirector
  • William ShawExecutive Officer
  • Stanley SternDirector
  • Ted WangDirector
  • Thomas SchreckDirector
  • Jason JonesExecutive Officer
  • Charles LiDirector
Offering amount
$3.5M
First sale
Feb 2021
Incorporated
Corporation, Nevada
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$5.2MofferedJun 2020 · 7 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • John F. GlennExecutive Officer
  • Charles LiDirector
  • William ShawExecutive Officer
  • Jack PeurachExecutive Officer, Director
  • Stanley SternDirector
  • Jason JonesExecutive Officer
  • Ted WangDirector
  • Thomas SchreckDirector
  • Marilyn HamiltonDirector
  • Steven ShermanExecutive Officer, Director
Offering amount
$5.2M
Sales commissions
$552.3K
Placement agents
H.C. Wainwright & Co., LLC
First sale
Jun 2020
Incorporated
Corporation, Nevada
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$22.8MraisedDec 2014 · 157 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Russ AngoldExecutive Officer
  • Marilyn HamiltonDirector
  • Jack PeurachDirector
  • Nathan HardingExecutive Officer, Director
  • Max Scheder-BieschinExecutive Officer
  • Thomas LoobyExecutive Officer
  • Daniel BorenDirector
  • Steven ShermanDirector
Offering amount
$30.3M
Amount sold
$22.8M
Sales commissions
$1.1M
Proceeds to insiders
$2.4M
Placement agents
Dinosaur Securities L.L.C., EDI Financial, Inc.
First sale
Nov 2014
Incorporated
Corporation, Nevada, 2012
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$27.4MraisedJan 2014 · 200 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Max Scheder-BieschinExecutive Officer
  • Daniel BorenDirector
  • Russ AngoldExecutive Officer
  • Steven ShermanDirector
  • Frank MoremanExecutive Officer
  • Nathan HardingExecutive Officer, Director
  • Jack PeurachDirector
  • Marilyn HamiltonDirector
Offering amount
$30.3M
Amount sold
$27.4M
Minimum investment
$5K
Sales commissions
$2.2M
Proceeds to insiders
$1.9M
Placement agents
Dinosaur Securities LLC, EDI Financial, Inc.
First sale
Jan 2014
Incorporated
Corporation, Nevada, 2012
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$2.3MraisedJan 2014 · 8 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Daniel BorenDirector
  • Jack PeurachDirector
  • Max Scheder-BieschinExecutive Officer
  • Russ AngoldExecutive Officer
  • Frank MoremanExecutive Officer
  • Nathan HardingExecutive Officer, Director
  • Marilyn HamiltonDirector
  • Steven ShermanDirector
Offering amount
$2.3M
Amount sold
$2.3M
First sale
Jan 2014
Incorporated
Corporation, Nevada, 2012
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$50.8MraisedJan 2014 · 110 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Nathan HardingExecutive Officer, Director
  • Russ AngoldExecutive Officer
  • Steven ShermanDirector
  • Marilyn HamiltonDirector
  • Max Scheder-BieschinExecutive Officer
  • Daniel BorenDirector
  • Jack PeurachDirector
  • Frank MoremanExecutive Officer
Offering amount
$50.8M
Amount sold
$50.8M
First sale
Jan 2014
Incorporated
Corporation, Nevada, 2012
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 3

by search overlap

Companies competing with Ekso Bionics for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Ekso Bionics do?
Ekso Bionics develops wearable exoskeleton robotics used to help people with paralysis stand and walk, to augment worker physical capabilities, and to support rehabilitation and R&D. It serves medical/rehabilitation and industrial markets in the healthcare robotics and medical device category.
Who are Ekso Bionics's investors?
Ekso Bionics's investors include Emery Capital, Lockheed Martin Ventures.
How much funding has Ekso Bionics raised?
Ekso Bionics has disclosed $103.3M raised across 4 of its 6 known rounds.
Where is Ekso Bionics headquartered?
Ekso Bionics is headquartered in Richmond, US.